世界卫生组织II级和III级脑膜瘤的转移:长期生存及关联因素分析
本研究回顾性分析131例手术切除的WHO II级或III级脑膜瘤患者,7例(发生率3.6%)在初次手术后平均30.9个月诊断转移。转移组总生存最差。与转移独立相关的因素包括主要血管受累(HR=9.9)、肿瘤复发时间小于24个月(HR=7.0)及次全切除未辅以放疗(HR=3.5)。
要点
- WHO II/III级脑膜瘤转移发生率为3.6%,平均于术后30.9个月诊断。
- 转移患者总生存最差,其次为无转移复发组,未复发组最好(P<0.001)。
- 次全切除后应辅以放疗以降低转移风险。
核心结论
- 转移的存在导致不良结局,并与较早的肿瘤复发和主要血管受累相关。
- 次全切除后应辅以放疗以降低转移风险。
- 需要进一步研究以确定循环或病理生物标志物,用于转移的早期检测。
研究设计与样本
- 回顾性分析基于2016年WHO标准经组织病理学确诊的手术切除WHO II级或III级脑膜瘤患者131例。
- 转移通过全身影像扫描后经手术切除或活检诊断。
- 分析临床因素与转移的关联。
主要发现
- 131例中7例(发生率3.6%)在肿瘤复发后诊断转移,平均于初次手术后30.9个月。
- 转移后复发组总生存最差,其次为无转移复发组,未复发组最好(P<0.001)。
- 与转移独立相关的因素为主要血管受累(HR=9.9,P=0.035)、肿瘤复发时间小于24个月(HR=7.0,P=0.036)、次全切除未对原发肿瘤辅以放疗(HR=3.5,P=0.047)。
- 分级或组织化学染色与转移无显著关联,而转移灶似乎比原发肿瘤更常见血管丰富。
关键数值与推荐
- 转移发生率3.6%(7/131例),平均诊断时间30.9个月。
- 主要血管受累HR=9.9(P=0.035)。
- 肿瘤复发时间小于24个月HR=7.0(P=0.036)。
- 次全切除未辅以放疗HR=3.5(P=0.047)。
- 三组总生存比较P<0.001。
临床怎么用
- 作者建议次全切除后应辅以放疗以降低转移风险。
- 作者认为需要进一步研究以确定循环或病理生物标志物,用于转移的早期检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Metastasis of World Health Organization (WHO) grade II or grade II meningiomas are rare. The aim of this study was to investigate their incidence, associated risk factors, and treatment course. METHODS: Patients with surgically resected WHO grade II or grade III meningiomas were reviewed based on histopathology with the 2016 WHO criteria. Metastasis was diagnosed through whole body image scan followed by surgical resection or biopsy. Clinical factors were analyzed for their association with metastasis. RESULTS: Among the 131 enrolled patients, metastasis was diagnosed after tumor relapse in 7 (incidence rate 3.6%) at a mean 30.9 months after the initial surgery. The metastasis after tumor relapse group had the worst overall survival, followed by tumor relapse without metastasis and nonrelapse groups (P < 0.001). The independent factors associated with metastasis were major vessel compromise by primary tumors (hazard ratio [HR] = 9.9, P = 0.035), tumor relapse time less than 24 months (HR = 7.0, P = 0.036), and subtotal resection without adjuvant radiotherapy to the primary tumor (HR = 3.5, P = 0.047). Neither grading nor histochemical staining was significantly associated with metastasis, whereas higher vascularity seemed to be more common in metastatic lesions than primary tumors. CONCLUSIONS: The presence of metastasis contributed to poor outcomes and was related to earlier tumor relapse and major vessel compromise. Subtotal resection should be followed by adjuvant radiotherapy to reduce the risk of metastasis. Further research is warranted to identify circulating or pathologic biomarkers for the early detection of metastasis.
引用
- Wang YC, Wu KL, Jung SM, et al. Metastasis of World Health Organization Grade II and Grade III Meningiomas: Long-Term Survival and Associated Factor Analysis. World Neurosurg. 2024. PMID: 39265944. doi:10.1016/j.wneu.2024.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。